Cadrenal Therapeutics, Inc. (CVKD) stock
CVKDNasdaqPharmaceutical PreparationsFiscal year ends December 31
$1.88+0.48 (+34.29%)
Close on Nov 17, 2026Market cap $6.71MP/E –Yield 877.66%
Cadrenal Therapeutics cash
Cash and short-term investments held at the end of each period.
Cadrenal Therapeutics's cash was $2.39M at Jun 30, 2026. For fiscal 2025 it was $4.01M, down 60.0% from the year before.
Annual cash
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $4.01M | -60.0% |
| FY2024 | Dec 31, 2024 | $10.02M | +19.2% |
| FY2023 | Dec 31, 2023 | $8.40M | – |
Quarterly cash
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $2.39M | -57.1% |
| Q1 FY2026 | Mar 31, 2026 | $2.31M | -68.5% |
| Q4 FY2025 | Dec 31, 2025 | $4.01M | -60.0% |
| Q3 FY2025 | Sep 30, 2025 | $3.86M | -11.5% |
| Q2 FY2025 | Jun 30, 2025 | $5.57M | +10.6% |
| Q1 FY2025 | Mar 31, 2025 | $7.34M | +11.7% |
| Q4 FY2024 | Dec 31, 2024 | $10.02M | +19.2% |
| Q3 FY2024 | Sep 30, 2024 | $4.36M | -52.1% |
| Q2 FY2024 | Jun 30, 2024 | $5.04M | +25.0% |
| Q1 FY2024 | Mar 31, 2024 | $6.57M | – |
| Q4 FY2023 | Dec 31, 2023 | $8.40M | – |
| Q3 FY2023 | Sep 30, 2023 | $9.11M | – |
| Q1 FY2023 | Mar 31, 2023 | $4.03M | – |
See a number that looks wrong?